أبوظبي
Zayed Higher Organization for People of Determination is implementing a new phase of tests for Emirati Genome Programme for people of determination and their families
Zayed Higher Organization for People of Determination is implementing a new phase of tests for Emirati Genome Programme for people of determination and their families, in cooperation with G42 Healthcare, as part of the Organization’s initiatives to benefit from advanced scientific research in the era of innovation and to follow scientific methods in providing care and rehabilitation programs and therapeutic sessions.
ZHO will receive people of determination and their families at the headquarters of the Zayed City Center for Care and Rehabilitation in Al Dhafra region on Monday, September 25, in Abu Dhabi region at the Abu Dhabi Center for Care and Rehabilitation on October 2, and at Abu Dhabi Autism Center on October 3, in Al Ain region at Al Ain Center for Care and Rehabilitation on October 9, and at Al Ain Autism Center, on October 10. The necessary tests will be carried out, with the aim of creating a healthier Emirati society, and enhancing treatment plans with a smart system with a distinguished level of treatment, prevention, control and prediction of diseases and epidemics.
Zayed Higher Organization for People of Determination is cooperating with G42 Healthcare in implementing the Emirati Genome Programme for people of determination and their families, through the development of a reference genome map for people of determination and their families by studying the complete genetic sequence using the latest technologies and providing a genetic database for use in the medical and diagnostic field, which contributes to developing codes for disabilities in an attempt to reduce disability, and hence to providing them with an outstanding therapeutic service.
The previous stages of the Emirati Genome Programme for people of determination and their families achieved great success, as they included 254 people of determination with various types of disabilities, and 226 parents, bringing the total number of participants to 480 participants, including 232 males and 248 females. The programme will enrich current health data for people of determination and their families by producing specific reference genes for citizens and advancing scientific discoveries on a large scale. Knowledge of the genetic sequence helps scientists and physicians to develop a treatment and preventive plan for the community based on the results of genetic analysis of citizens.
The Emirati Genome Programme is a national project that aims to use the genetic data of the State's citizens, analyze it and benefit from it to improve the public health of Emiratis. The Programme provides citizens with a special reference genome and integrates genetic data into the healthcare management database. It also uses advanced sequencing technology to create a genome database, as part of clinical care with the aim of enhancing the prevention of hereditary and chronic diseases such as obesity, diabetes, blood pressure, cancer, and asthma, and reaching a personalized treatment for each patient according to genetic factors through the use of genetic sciences and innovative modern technologies regarding genetic profiling and sequencing to identify the DNA fingerprint.
In harmony with the goal of the Emirati Genome Programme, the Emirati Genome Programme for people of determination and their families aims to develop a comprehensive map of genetic data for Emiratis to accelerate the pace of preventive healthcare solutions and accurate diagnosis for current and future generations. The Programme will study the genes of citizens across the UAE using the latest DNA sequencing technologies, and also benefit from the analytical power of AI technology. It aims to use, analyze and benefit from the genetic data of the Emiratis to improve their general health, develop proactive treatment plans, with the aim of enhancing the prevention of hereditary and chronic diseases and reaching a personalized treatment for each patient, according to genetic factors, through the use of genetic sciences and innovative modern techniques regarding profiling and genetic sequencing to identify DNA fingerprint.
The Programme will contribute to predicting the susceptibility to certain diseases, by reading the complete genome, and developing a treatment and preventive plan based on the results of the genetic analysis of Emiratis. The results of the Programme will be used to develop new treatments and tests, enabling healthcare workers to provide several options for diagnosis and medical treatment, in addition to providing customized and preventive programs tailored to the genetic makeup of the individual.
ZHO will receive people of determination and their families at the headquarters of the Zayed City Center for Care and Rehabilitation in Al Dhafra region on Monday, September 25, in Abu Dhabi region at the Abu Dhabi Center for Care and Rehabilitation on October 2, and at Abu Dhabi Autism Center on October 3, in Al Ain region at Al Ain Center for Care and Rehabilitation on October 9, and at Al Ain Autism Center, on October 10. The necessary tests will be carried out, with the aim of creating a healthier Emirati society, and enhancing treatment plans with a smart system with a distinguished level of treatment, prevention, control and prediction of diseases and epidemics.
Zayed Higher Organization for People of Determination is cooperating with G42 Healthcare in implementing the Emirati Genome Programme for people of determination and their families, through the development of a reference genome map for people of determination and their families by studying the complete genetic sequence using the latest technologies and providing a genetic database for use in the medical and diagnostic field, which contributes to developing codes for disabilities in an attempt to reduce disability, and hence to providing them with an outstanding therapeutic service.
The previous stages of the Emirati Genome Programme for people of determination and their families achieved great success, as they included 254 people of determination with various types of disabilities, and 226 parents, bringing the total number of participants to 480 participants, including 232 males and 248 females. The programme will enrich current health data for people of determination and their families by producing specific reference genes for citizens and advancing scientific discoveries on a large scale. Knowledge of the genetic sequence helps scientists and physicians to develop a treatment and preventive plan for the community based on the results of genetic analysis of citizens.
The Emirati Genome Programme is a national project that aims to use the genetic data of the State's citizens, analyze it and benefit from it to improve the public health of Emiratis. The Programme provides citizens with a special reference genome and integrates genetic data into the healthcare management database. It also uses advanced sequencing technology to create a genome database, as part of clinical care with the aim of enhancing the prevention of hereditary and chronic diseases such as obesity, diabetes, blood pressure, cancer, and asthma, and reaching a personalized treatment for each patient according to genetic factors through the use of genetic sciences and innovative modern technologies regarding genetic profiling and sequencing to identify the DNA fingerprint.
In harmony with the goal of the Emirati Genome Programme, the Emirati Genome Programme for people of determination and their families aims to develop a comprehensive map of genetic data for Emiratis to accelerate the pace of preventive healthcare solutions and accurate diagnosis for current and future generations. The Programme will study the genes of citizens across the UAE using the latest DNA sequencing technologies, and also benefit from the analytical power of AI technology. It aims to use, analyze and benefit from the genetic data of the Emiratis to improve their general health, develop proactive treatment plans, with the aim of enhancing the prevention of hereditary and chronic diseases and reaching a personalized treatment for each patient, according to genetic factors, through the use of genetic sciences and innovative modern techniques regarding profiling and genetic sequencing to identify DNA fingerprint.
The Programme will contribute to predicting the susceptibility to certain diseases, by reading the complete genome, and developing a treatment and preventive plan based on the results of the genetic analysis of Emiratis. The results of the Programme will be used to develop new treatments and tests, enabling healthcare workers to provide several options for diagnosis and medical treatment, in addition to providing customized and preventive programs tailored to the genetic makeup of the individual.
Page Last Update: 21 September 2023